EUVIMEDEUVIMED entdecken
Crossref

Do We Need a New Nomenclature for Atypical Antipsychotics? A Survey of Health Care Professionals and Patients

Greg Mattingly, Tina Matthews-Hayes, Mehul D Patel, Kenneth Kramer, Stephen M Stahl

The Primary Care Companion For CNS Disorders · 2023

DOI: 10.4088/pcc.22m03331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Primary Care Companion For CNS Disorders, 2023. Verfasst von Greg Mattingly und 4 weiteren Autor:innen. Beteiligte Einrichtung: Washington University School of Medicine, St Louis, Missouri. Hauptthemen laut MEDLINE: Antipsychotic Agents, Major Depressive Disorder, Bipolar Disorder. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The current nomenclature for atypical antipsychotics does not indicate that they are used to treat nonpsychotic conditions (eg, bipolar disorder, major depressive disorder), which could have negative implications for both health care providers (HCPs) and patients. The objective of this study was to evaluate how the atypical antipsychotic class name affects HCPs who treat bipolar disorder and patients who receive the diagnosis.

Methods

Nationwide surveys of primary care and psychiatric HCPs (n = 200) and patients with bipolar disorder (n = 200) were conducted to assess perspectives regarding current atypical antipsychotic nomenclature. HCP opinion about a change in class name was also evaluated. The self-administered electronic surveys were completed by HCPs from May 22, 2020, to June 1, 2020, and by patients from August 25, 2020, to September 7, 2020.

Results

Compared with the mood stabilizer class name, the atypical antipsychotic name elicited stronger negative feelings from both HCPs and patients. Most HCPs avoided bringing up the atypical antipsychotic name with patients (72%), often due to fear of negative reactions. Despite being approved for bipolar mania and depression, only 48% and 39% of HCPs indicated that atypical antipsychotics were appropriate for these disorders, respectively. If an appropriate alternative for the term atypical antipsychotic was available for bipolar disorder, 71% of HCPs said they were likely to change their class-related behaviors. Most patients had never heard of the atypical antipsychotic class name (69%). Significantly more patients had negative reactions (eg, worry, fear, confusion) to the idea of their HCP prescribing an atypical antipsychotic versus a mood stabilizer (25% vs 6%). Compared with mood stabilizers, patients were less likely to take an atypical antipsychotic immediately as prescribed.

Conclusions

Significantly more HCPs and patients had negative reactions to atypical antipsychotic nomenclature compared with mood stabilizer nomenclature for treating bipolar disorder. The broad descriptive atypical antipsychotic class name may not support the standard of care for the treatment of bipolar disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsMajor Depressive DisorderBipolar DisorderHumansAntimanic AgentsAnticonvulsants

Substanzen

Antipsychotic AgentsAntimanic AgentsAnticonvulsants

Autor:innen und Institutionen

  • Washington University School of Medicine, St Louis, Missouri.
  • Corresponding author: Greg Mattingly, MD, Washington University School of Medicine, 4801 Weldon Spring Pkwy, Ste 300, St Charles, MO 63304 (greg@mattingly.com).
  • Seaside Behavioral Health, Virginia Beach, Virginia.
  • AbbVie, Madison, New Jersey.
  • Department of Psychiatry, University of California, San Diego, California.

Zitieren

APA

Mattingly, G., Matthews-Hayes, T., Patel, M. D., Kramer, K., & Stahl, S. M. (2023). Do We Need a New Nomenclature for Atypical Antipsychotics? A Survey of Health Care Professionals and Patients. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.22m03331

Vancouver

Mattingly G, Matthews-Hayes T, Patel MD, Kramer K, Stahl SM. Do We Need a New Nomenclature for Atypical Antipsychotics? A Survey of Health Care Professionals and Patients. The Primary Care Companion For CNS Disorders. 2023. doi:10.4088/pcc.22m03331

BibTeX
@article{Mattingly2023,
  author = {Mattingly, Greg and Matthews-Hayes, Tina and Patel, Mehul D and Kramer, Kenneth and Stahl, Stephen M},
  title = {Do We Need a New Nomenclature for Atypical Antipsychotics? A Survey of Health Care Professionals and Patients},
  journal = {The Primary Care Companion For CNS Disorders},
  year = {2023},
  doi = {10.4088/pcc.22m03331}
}
Kostenlos starten →